FLNA
Filana Therapeutics, Inc. NASDAQ Listed Jul 14, 2000$1.35
Mkt Cap $65.5M
52w Low $1.34
0.3% of range
52w High $4.98
50d MA $1.81
200d MA $2.44
P/E (TTM)
-0.8x
EV/EBITDA
-0.0x
P/B
1.0x
Debt/Equity
0.0x
ROE
-122.3%
P/FCF
-3.0x
RSI (14)
—
ATR (14)
—
Beta
-0.68
50d MA
$1.81
200d MA
$2.44
Avg Volume
546.2K
Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier in May 1998 and is headquartered in Austin, TX.
6801 N. Capital of Texas Highway · Austin, TX 78731 · US
Data updated apr 25, 2026 9:21am
· Source: massive.com